Rosuvastatin Effect on Telomere-telomerase System in ACS
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 400 participants.
Also called NCT02299245
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 400 participants
- Registry
-
NCT02299245
-
- Start date
- (registry gives no type)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Not reported
- Registry status
- Unknown status
Technical summary
Registry record NCT02299245. Randomized; no masking; primary purpose treatment. Start 2014-10 (registry gives no type); primary completion 2016-07 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Rosuvastatin Effect on Telomere-telomerase System in ACS
- Condition
- Telomere Shortening
- Condition
- Telomere Length, Mean Leukocyte
- Condition
- 22q Telomere Deletion Syndrome
- Intervention (Drug)
- rosuvastatin
- Lead sponsor
- Xiao-dong Zhuang
- Collaborator
- Sun Yat-sen University
Record details
- Record id
cardio:ct-nct02299245- Content hash
85522ae9088594f59eb6e7e4856b67ca222fd74c82768939ff020bafa6ceb2c0